封面
市場調查報告書
商品編碼
2137053

披衣菌感染衣原體和淋病奈瑟菌檢測市場規模、細分市場、佔有率、法規、報銷及至 2036 年的預測。

Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

該報告題為《披衣菌感染衣原體和淋病奈瑟菌檢測的市場規模、細分、佔有率、監管、報銷狀況及至 2036 年的預測》,旨在可視化體外診斷 (IVD) 治療領域的定量和定性市場趨勢。

披衣菌感染衣原體檢測用於感染疾病可引起沙眼、淋巴肉芽腫、非淋球菌性尿道炎、子宮頸炎、輸卵管炎和骨盆腔炎的感染。淋病奈瑟菌檢測用於診斷淋病,淋病是一種性行為感染的尿道感染。

披衣菌感染衣原體感染疾病主要透過性活躍的青少年和成年人之間的性接觸傳播。此外,它還可以在陰道分娩過程中由母親傳染給嬰兒。

針對39個目標國家,每個國家都提供了一個基於引用數據、採用顏色編碼的市場模型,其中納入了流行病學指標。互動式Excel格式的交付成果包含金錢價值、數量、產品使用、平均售價、市場規模和企業市場占有率分析(如有)。此外,分析師的評論,包括定性見解,為定量數據提供了背景資訊。

市場模式的主要組成如下:

目前市面上可用的披衣菌感染披衣菌和淋病奈瑟菌檢測套組,以及不斷變化的市場競爭格局:

  • 對關鍵產業趨勢的深入分析。
  • 2015 年至 2036 年披衣菌感染衣原體及淋病奈瑟菌檢測的年度總市場銷售額(按細分市場分類)及市場展望。
  • 市場層級的數據,包括銷售量、平均售價和市場價值。

對全球、區域和特定國家市場的具體見解:

  • 報告提供針對特定市場的定性訊息,並將全球趨勢進一步細分為區域趨勢。此外,GlobalData 分析師還提供獨特的、針對特定國家的市場洞察。
  • 對披衣菌感染衣原體和淋病奈瑟菌檢測市場進行SWOT分析。
  • 披衣菌感染披衣菌和淋病奈瑟菌檢測市場的競爭考察和趨勢。

透過獲得真正全面的概覽,包括對醫療保健系統的概述,您可以加深對市場的理解。此外,在「市場進入」部分,您可以利用有關報銷政策和監管條件的信息,更深入地了解市場動態。

  • 各國醫療保健系統概覽。
  • 各國具體的還款政策。
  • 各國醫療設備法規。

憑藉可靠的調查方法和數據來源,該模型能夠提供全面且準確的市場概覽。來自需求方和供應方(包括關鍵意見領袖)的第一手資訊均整合到企業聯合組織模型中。此外,該模型還利用真實世界的資料來源來捕捉市場趨勢,包括政府手術資料庫、醫院採購資料庫和專有線上資料庫。

涵蓋的公司包括:羅氏診斷國際有限公司、雅培實驗室、賽默飛世爾科技公司、Cepheid公司、貝克頓·迪金森公司、Hologic公司、Quidel公司、Bio-Rad Laboratories公司、Trinity Biotech Plc、ZeptoMetrix LLC等。

目標國家:美國、英國、德國、法國、義大利、西班牙、巴西、中國、印度、俄羅斯、日本、澳洲、加拿大、墨西哥、韓國、丹麥、愛爾蘭、荷蘭、紐西蘭、南非、瑞典、瑞士、奧地利、比利時、芬蘭、以色列、挪威、波蘭、葡萄牙、台灣、捷克、希臘、匈牙利、土耳其、埃及、沙烏地阿拉伯、阿拉伯聯合大公國、阿根廷、智利

調查範圍

這個市場模型提供了其他任何資訊來源都無法找到的關鍵專家見解。它揭示了目標市場的定性和定量趨勢。以下人群必須閱讀此模型:

  • 對於需要深入了解披衣菌感染衣原體和淋病奈瑟菌檢測市場以製定策略規劃和投資決策的首席行銷長 (CMO) 來說,這至關重要。
  • 採購負責人需要了解供應基礎的關鍵要素,以便做出有關供應商選擇和管理的決策。
  • 私募股權投資者需要對市場有更深入的了解,才能發現潛在的投資機會並評估其價值。

購買原因

利用這種模型,可以實現以下目標:

  • 透過確定關鍵公司並仔細審查其開發平臺中的產品,您可以製定和設計實施和許可策略。
  • 您可以了解影響和推動披衣菌感染衣原體和淋病奈瑟菌檢測市場的趨勢,並制定商業策略。
  • 了解關鍵趨勢、創新產品和技術、市場細分以及未來可能影響披衣菌感染衣原體和淋病奈瑟菌檢測市場的公司,有助於擴大收入。
  • 透過了解競爭格局並分析領導企業的市場佔有率,我們制定有效的銷售和行銷策略。
  • 我們尋找具有強大產品系列潛力的新興企業,並制定有效的應對策略以獲得競爭優勢。
  • 本報告追蹤了 2015 年至 2036 年全球及各國披衣菌感染衣原體和淋病奈瑟菌檢測設備的銷售趨勢。
  • 確定在整合、投資和策略聯盟方面提供最大機會的市場類別和細分市場,並據此建立您的銷售和行銷活動。
簡介目錄
Product Code: GDME941MM

Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Chlamydia trachomatis Tests are carried out to diagnose infections, which can result in trachoma, lymphogranuloma venereum, nongonococcal urethritis, cervicitis, salpingitis, pelvic inflammatory disease. Neisseria gonorrhoeae Tests are carried out to diagnose the sexually transmitted genitourinary infection gonorrhoea.

Chlamydia trachomatis infections mainly occur in sexually active adolescents and adults through sexual contact. In addition, infection may be passed from mother to child during vaginal birth.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market revenue by segment and market outlooks from 2015- 2036.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market.
  • Competitive dynamics insights and trends provided for Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Roche Diagnostics International Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc , Cepheid Inc, Becton Dickinson and Co ,Hologic Inc, Quidel Corp, Bio-Rad Laboratories Inc, Trinity Biotech Plc, ZeptoMetrix LLC, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.